News | April 22, 2026
Zyax Chem takes 26% stake in Gaymed Labs
Targets high-growth eye care expansion push
Targets high-growth eye care expansion push
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
Dr. Bandichhor brings nearly two decades of experience from Dr. Reddy's Laboratories
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The company reported a net profit of Rs 46.15 crore in Q2 FY25 as compared to Rs 23.88 crore in Q2 FY24
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Subscribe To Our Newsletter & Stay Updated
